Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

GSK

Gsk (GSK)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK
DataOraFonteTitoloSimboloCompagnia
19/11/202416:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
19/11/202410:24Alliance NewsAlliance NewsGSK hails positive results for linerixibat in treating relentless itchLSE:GSKGsk Plc
19/11/202408:00RNS Regulatory NewsGSK PLC GLISTEN Trial of Linerixibat Meets EndpointLSE:GSKGsk Plc
14/11/202409:54Alliance NewsAlliance NewsGSK hails survival results in blood cancer patients with BlenrepLSE:GSKGsk Plc
14/11/202408:00RNS Regulatory NewsGSK PLC GSK announces overall survival results for BlenrepLSE:GSKGsk Plc
13/11/202416:00RNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
11/11/202416:01RNS Regulatory NewsGSK PLC GSK publishes provisional 2025 dividend datesLSE:GSKGsk Plc
04/11/202417:16Alliance NewsAlliance NewsDIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sellsLSE:GSKGsk Plc
01/11/202416:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
30/10/202410:28Alliance NewsAlliance NewsTOP NEWS: GSK backs guidance despite third-quarter hit from ZantacLSE:GSKGsk Plc
30/10/202408:00RNS Regulatory NewsGSK PLC 3rd Quarter ResultsLSE:GSKGsk Plc
29/10/202413:48Alliance NewsAlliance NewsGSK inks deal to buy lupus therapy from Chimagen for USD300 millionLSE:GSKGsk Plc
24/10/202410:22Alliance NewsAlliance NewsIN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSVLSE:GSKGsk Plc
24/10/202408:00RNS Regulatory NewsGSK PLC New positive Arexvy data in younger adults at riskLSE:GSKGsk Plc
16/10/202409:33Alliance NewsAlliance NewsGSK's application for urinary tract infections drug is acceptedLSE:GSKGsk Plc
16/10/202408:00RNS Regulatory NewsGSK PLC FDA accepts new drug application for gepotidacinLSE:GSKGsk Plc
14/10/202409:54Alliance NewsAlliance NewsTOP NEWS: GSK gets positive result from sinus disease treatment trialsLSE:GSKGsk Plc
14/10/202408:00RNS Regulatory NewsGSK PLC Positive results of ANCHOR trials of depemokimabLSE:GSKGsk Plc
10/10/202412:48IH Market NewsU.S. Futures Fall Slightly as Investors Await CPI Data; Oil Prices RiseLSE:GSKGsk Plc
10/10/202410:24Alliance NewsAlliance NewsEXTRA: GSK's Zantac update clears "indigestion" but eyes turn to jabsLSE:GSKGsk Plc
09/10/202420:59Alliance NewsAlliance NewsTOP NEWS: GSK to settle 80,000 Zantac cases for up to USD2.2 billionLSE:GSKGsk Plc
09/10/202418:48RNS Regulatory NewsGSK PLC Zantac (ranitidine) litigation settlementsLSE:GSKGsk Plc
08/10/202414:18Alliance NewsAlliance NewsGSK trial proves RSV vaccine efficacy after three full seasonsLSE:GSKGsk Plc
08/10/202412:45RNS Regulatory NewsGSK PLC Positive efficacy data of Arexvy over 3 seasonsLSE:GSKGsk Plc
24/09/202410:16Alliance NewsAlliance NewsTOP NEWS: GSK celebrates positive EU opinion of liquid Menveo vaccineLSE:GSKGsk Plc
24/09/202408:00RNS Regulatory NewsGSK PLC Positive EU opinion for GSK liquid Menveo vaccineLSE:GSKGsk Plc
18/09/202415:00Alliance NewsAlliance NewsGSK reaches further two settlements regarding ZantacLSE:GSKGsk Plc
18/09/202414:20RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
17/09/202410:18Alliance NewsAlliance NewsGSK says Blenrep combinations accepted for review in JapanLSE:GSKGsk Plc
17/09/202408:00RNS Regulatory NewsGSK PLC Japan Filing Acceptance: Blenrep Multiple MyelomaLSE:GSKGsk Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network